Clinical Trials Logo

Clinical Trial Summary

Two arms RCT is design, patients with pancreatic body or tail adenocarcinoma will be randomly assigned to the Radical Antegrade Modular Pancreaticosplenectomy (RAMPS) group or Standard Retrograde Pancreatosplenectomy (SRPS) group. The primary objective is to evaluate the effect of RAMPS on the overall survival of patients with resectable body and tail pancreatic ductal adenocarcinoma. And the secondary objective is to evaluate the disease-free survival, R0 resection rate, number of retrieved lymph nodes and perioperative outcomes like postoperative complication rate, severe complications, mortality and functional recovery time between the experimental group and control group.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04253847
Study type Interventional
Source Ruijin Hospital
Contact Yuanchi Weng, MD
Phone +86-13774209138
Email wyuanchi@126.com
Status Not yet recruiting
Phase N/A
Start date February 15, 2020
Completion date February 28, 2027